Daniel Dereser joined the Boiron Canada team as Director of Medical Development before becoming, in 2015, President and CEO of the Canadian subsidiary of Laboratoires Boiron.
With more than 18 years of expertise in France, the USA, and Canada in the homeopathy industry, and a graduate with a Doctorate in Pharmacy (France) and in Industrial Pharmacy, Daniel Dereser began his career at Les Laboratoires Boiron in France as a pharmacist responsible for manufacturing production. He later became the head pharmacist at Boiron USA, also acting as a specialist in professional education, pharmacist, and Director of Medical Development for more than 11 years.
He is also a speaker for the Western University of California, focusing on integrative medicine and homeopathy. A passionate communicator, Daniel has been actively involved since 2019 with the Coalition for Homeopathy in Quebec (CPHQ) and, since 2021, with the Canadian Coalition for Homeopathy (CCFH)—both dedicated to promoting and defending homeopathy in Quebec and across Canada.
He consistently seeks opportunities to advance issues related to homeopathy and contributes to patient well-being by promoting an integrative, patient-centered approach to medicine.
Daniel currently serves on the Board of Directors of the Homeopathic Pharmaceutical Association of Canada (HPAC).
